Dr. Donna Michelle Esposito , MD
Ophthalmology • Fishkill, NY
200 Westage Business Ctr Dr Ste 110
Fishkill, NY 125242269
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on July 22, 2010; this date does not establish years in practice.
-
Published CMS data list 2,110 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 92014 — Established patient complete exam of visual system: 627 service units.
- 92012 — Established patient problem focused exam of visual system: 490 service units.
- 92134 — Imaging of retina: 213 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 15 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,354 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Latanoprost — 270 prescription fills, including refills.
- Prednisolone Acetate — 145 prescription fills, including refills.
- Restasis (Cyclosporine) — 119 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 26 records in the table · Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Medicare Part B services among clinicians listed under Ophthalmology in New York (2024, 1,153 clinicians with data). Median for this group: 1,740. Middle half: 661 to 3,640.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 1,466 in 2020 to 2,110 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
200 Westage Business Ctr Dr Ste 110
Fishkill, NY 125242269
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Hudson Valley Eye Surgeons. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
New York Medical College
2010
What Public CMS Data Show
Ophthalmology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
720 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $245,787 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $175,119 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
2,177 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$322,142 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $851.85 across 33 records.
By nature of payment
- Food and Beverage: $851.85 across 33 records.
Reporting-company totals (3 largest of 11)
- Bausch & Lomb Americas Inc.: $226.63 across 9 records.
- Tarsus Pharmaceuticals, Inc.: $136.73 across 4 records.
- SUN PHARMACEUTICAL INDUSTRIES INC.: $101.26 across 4 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
16 years (graduated 2010)
CMS Doctors and Clinicians data list 2010 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2010
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Esposito has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Esposito as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Fishkill and New York
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Close to the middle for clinicians listed under Ophthalmology in New York (2024, 1,153 clinicians with data). Median for this group: 1,740. Middle half: 661 to 3,640.
Too few clinicians listed under Ophthalmology in Fishkill have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
Close to the middle for clinicians listed under Ophthalmology in New York (2024, 1,153 clinicians with data). Median for this group: $179,154. Middle half: $63,528 to $368,645.
Too few clinicians listed under Ophthalmology in Fishkill have Medicare Part B data for 2024 to compare.
Paid by Medicare
Close to the middle for clinicians listed under Ophthalmology in New York (2024, 1,153 clinicians with data). Median for this group: $129,242. Middle half: $44,806 to $269,713.
Too few clinicians listed under Ophthalmology in Fishkill have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Ophthalmology in New York (2024, 1,223 clinicians with data). Median for this group: 1,052. Middle half: 363 to 2,319.
Too few clinicians listed under Ophthalmology in Fishkill have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 70% of clinicians listed under Ophthalmology in New York (2024, 1,223 clinicians with data). Median for this group: $130,599. Middle half: $25,667 to $327,194.
Too few clinicians listed under Ophthalmology in Fishkill have Medicare Part D data for 2024 to compare.
9 active clinicians are listed under Ophthalmology with a practice address in Fishkill, NY (1,818 in New York).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 44% from 1,466 in 2020 to 2,110 in 2024.
- 2020: 1,466
- 2021: 2,003
- 2022: 2,176
- 2023: 2,183
- 2024: 2,110
-
Medicare-allowed amount
Medicare-allowed amount increased 53% from $161,158 in 2020 to $245,787 in 2024.
- 2020: $161,158
- 2021: $230,972
- 2022: $259,715
- 2023: $247,028
- 2024: $245,787
-
Paid by Medicare
Paid by Medicare increased 57% from $111,827 in 2020 to $175,119 in 2024.
- 2020: $111,827
- 2021: $164,174
- 2022: $182,021
- 2023: $176,492
- 2024: $175,119
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 47% from 924 in 2020 to 1,354 in 2024.
- 2020: 924
- 2021: 1,233
- 2022: 1,193
- 2023: 1,117
- 2024: 1,354
-
30-day fills
30-day fills increased 55% from 1,408 in 2020 to 2,177 in 2024.
- 2020: 1,408
- 2021: 1,791
- 2022: 1,724
- 2023: 1,756
- 2024: 2,177
-
Part D drug cost
Part D drug cost increased 71% from $188,717 in 2020 to $322,142 in 2024.
- 2020: $188,717
- 2021: $255,815
- 2022: $243,489
- 2023: $268,384
- 2024: $322,142
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $265.20 in 2021 to $851.85 in 2025.
- 2021: $265.20
- 2022: $284.97
- 2023: $725.67
- 2024: $645.58
- 2025: $851.85
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 33 records totaling $851.85.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Bausch & Lomb Americas Inc. |
Food and Beverage
In-kind items and services
|
MIEBO | General | $103.91 |
| Tarsus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
XDEMVY | General | $37.54 |
| Tarsus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
XDEMVY | General | $33.98 |
| Tarsus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
XDEMVY | General | $33.55 |
| Tarsus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
XDEMVY | General | $31.66 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
Cequa | General | $31.51 |
| Alcon Vision LLC |
Food and Beverage
In-kind items and services
|
Clareon | General | $31.31 |
| Alcon Vision LLC |
Food and Beverage
In-kind items and services
|
Rocklatan | General | $30.47 |
| ANI Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
PURIFIED CORTROPHIN GEL | General | $30.15 |
| ANI Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
PURIFIED CORTROPHIN GEL | General | $28.90 |
| Dompe US, Inc. |
Food and Beverage
In-kind items and services
|
OXERVATE | General | $28.78 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUMIGAN | General | $27.27 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $26.42 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
Cequa | General | $25.37 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
Cequa | General | $25.06 |
| BIOTISSUE HOLDINGS INC. |
Food and Beverage
In-kind items and services
|
— | General | $25.00 |
| Dompe US, Inc. |
Food and Beverage
In-kind items and services
|
OXERVATE | General | $24.57 |
| Alcon Vision LLC |
Food and Beverage
In-kind items and services
|
TRYPTYR | General | $22.94 |
| Bausch & Lomb Americas Inc. |
Food and Beverage
In-kind items and services
|
VYZULTA | General | $21.87 |
| Dompe US, Inc. |
Food and Beverage
In-kind items and services
|
OXERVATE | General | $21.14 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TEPEZZA | General | $19.58 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
Cequa | General | $19.32 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUMIGAN | General | $18.90 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $18.17 |
| Ocular Therapeutix, Inc. |
Food and Beverage
In-kind items and services
|
DEXTENZA | General | $17.65 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
92014
Established patient complete exam of visual system
|
627 | 508 | $135.12 | $131.65 |
|
92012
Established patient problem focused exam of visual system
|
490 | 295 | $95.68 | $93.51 |
|
92134
Imaging of retina
|
213 | 172 | $44.12 | $41.78 |
|
92133
Imaging of optic nerve
|
168 | 161 | $40.25 | $37.58 |
|
92083
Exam of visual field with extended testing
|
130 | 123 | $67.93 | $66.82 |
|
92136
Measurement of corneal curvature and depth of eye
|
111 | 80 | $54.83 | $42.89 |
|
66984
Removal of cataract with insertion of prosthetic lens
|
90 | 59 | $600.28 | $563.50 |
|
92004
New patient complete exam of visual system
|
81 | 81 | $158.21 | $155.90 |
|
68761
Closure of tear duct opening using plug
|
52 | 38 | $299.35 | $215.86 |
|
92201
Extended exam of the back part of the eye with retinal drawing
|
39 | 32 | $26.12 | $25.70 |
|
66821
Removal of recurring cataract in lens capsule using a laser
|
30 | 25 | $433.57 | $339.63 |
|
76514
Ultrasound scan of cornea to determine thickness
|
29 | 29 | $12.14 | $11.36 |
|
92002
New patient problem focused exam of visual system
|
23 | 23 | $92.74 | $89.08 |
|
67820
Removal of eyelashes using forceps
|
15 | 12 | $19.76 | $18.82 |
|
92020
Exam of the internal drainage system of eye
|
12 | 12 | $29.02 | $28.60 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Latanoprost | Latanoprost | 270 | 13,546 | $3,406.36 | 71 |
| Prednisolone Acetate | Prednisolone Acetate | 145 | 3,709 | $4,618.50 | 95 |
| Restasis | Cyclosporine | 119 | 4,860 | $98,677.14 | 45 |
| Brimonidine Tartrate | Brimonidine Tartrate | 98 | 5,130 | $4,309.10 | 36 |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 88 | 1,460 | $1,042.33 | 74 |
| Timolol Maleate | Timolol Maleate | 81 | 5,122 | $855.83 | 30 |
| Xiidra | Lifitegrast | 81 | 3,721 | $82,040.43 | 29 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 52 | 3,368 | $643.84 | 16 |
| Moxifloxacin | Moxifloxacin Hcl | 52 | 809 | $1,123.90 | 35 |
| Dorzolamide Hcl | Dorzolamide Hcl | 46 | 3,118 | $1,040.81 | 17 |
| Cyclosporine | Cyclosporine | 41 | 1,875 | $14,815.07 | 17 |
| Lumigan | Bimatoprost | 38 | 2,965 | $25,016.22 | 15 |
| Miebo | Perfluorohexyloctane/Pf | 35 | 1,505 | $31,852.67 | — |
| Erythromycin | Erythromycin Base | 27 | 490 | $305.04 | 22 |
| Rocklatan | Netarsudil Mesylat/Latanoprost | 25 | 1,315 | $17,276.37 | — |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 23 | 1,270 | $4,425.22 | — |
| Simbrinza | Brinzolamide/Brimonidine Tart | 18 | 780 | $4,072.31 | — |
| Dorzolamide-Timolol | Dorzolamide/Timolol/Pf | 18 | 645 | $1,695.48 | — |
| Doxycycline Hyclate | Doxycycline Hyclate | 14 | 403 | $1,335.24 | — |
| Azelastine Hcl | Azelastine Hcl | 13 | 748 | $190.77 | — |
| Prolensa | Bromfenac Sodium | 12 | 435 | $4,106.31 | — |
| Cequa | Cyclosporine | 12 | 660 | $11,986.16 | — |
| Travoprost | Travoprost | 12 | 952 | $3,133.42 | — |
| Tafluprost | Tafluprost/Pf | 12 | 600 | $2,102.01 | — |
| Ofloxacin | Ofloxacin | 11 | 264 | $90.73 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OPHTHALMOLOGY
I20101123001007
NY
5698961126
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Hudson Valley Eye Surgeons
200 Westage Business Ctr Dr, Fishkill, NY 125242269
Phone: 8458969280
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Osteopathic Medicine (D.O.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 200 WESTAGE BUSINESS CTR DR STE 110, FISHKILL, NY 125242269 (Tel: 8458969280)
Registered at 200 WESTAGE BUSINESS CTR DR STE 110, FISHKILL, NY 125242269 (Tel: 8458969280)
NPI status registered as active in NPPES database
Registered at 820 UNION ST, HUDSON, NY 125343004 (Tel: 5188283391)
Registered at 820 UNION ST, HUDSON, NY 125343004 (Tel: 5188283391)
Recorded as DONNA ESPOSITO, M.D
Ophthalmology (license number reported to NPPES: NY 254681-1)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Ophthalmology Specialists in Fishkill
- Dr. Pat-Michael Palmiero, MD
- David Scheer
- Dr. John Nichols, MD
- Dr. Greg Diamond, MD
- Dr. David Steinberg, MD
- Dr. Matthew Schear, DO
Mailing Address
200 Westage Business Ctr Dr Ste 110
Fishkill, NY 125242269
Phone: 8458969280